# Tracking Treatment Pathways in Adult Patients With Hyperkalemia.

> **NCT05408039** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1331 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05408039
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-14
- **Primary completion:** 2024-12-19
- **Final completion:** 2024-12-19
- **Target enrollment:** 1331 (ACTUAL)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05408039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05408039, "Tracking Treatment Pathways in Adult Patients With Hyperkalemia.". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT05408039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*